Do Probiotics Have An Effect On Sexual Health Or Function?

Quick answer

Probiotics may improve sexual function and satisfaction in specific populations such as women and men with depression treated with SSRIs, women with polycystic ovary syndrome, and postmenopausal women. Evidence also suggests potential benefits in sexual function in multiple sclerosis patients and pessary users. However, effects are strain-specific and population-specific, and evidence is limited to certain clinical contexts rather than general sexual health improvement.

🔬 What the research shows

Several high-quality randomized controlled trials (PMID: 38216917, 42059569) demonstrated that probiotic supplementation (including strains like Bifidobacterium bifidum and Lactobacillus acidophilus as part of multi-strain products such as Lactofem) improved sexual function and satisfaction in women and men with depressive disorders undergoing SSRI treatment. Another RCT (PMID: 36096842) showed improved sexual function and pregnancy rates in women with polycystic ovary syndrome receiving probiotics plus letrozole. Postmenopausal women also showed improved sexual function and quality of life with Lactobacillus acidophilus supplementation (PMID: 41326645, 41186601). In patients with progressive multiple sclerosis, synbiotics improved sexual function alongside fatigue and pain (PMID: 37651846). Vaginal Lactobacillus acidophilus tablets provided satisfaction comparable to ultra-low-dose oestriol in pessary users (PMID: 40464696). These findings indicate probiotics may benefit sexual function in specific clinical populations, often linked to underlying conditions affecting sexual health. Evidence from athletic performance and general population studies does not support broad claims of probiotics improving sexual function. Safety profiles were generally favorable with rare adverse events reported. Limitations include population specificity, short intervention durations, and lack of long-term follow-up.

Best studied probiotic strains

Bifidobacterium bifidum (part of Lactofem multi-strain product)

RCT in women with depression on SSRIs showed significant improvement in Female Sexual Function Index (FSFI) and sexual satisfaction after 8 weeks (PMID: 38216917).

Studied for: Depression with SSRI-induced sexual dysfunction in women

Used in combination with Lactobacillus acidophilus, L. rutri, and L. fermentum; effects observed as adjunct to SSRI treatment.

Multi-strain Lactofem (including Bifidobacterium bifidum and Lactobacillus acidophilus)

RCT in men with mild to moderate depression on Escitalopram showed improved erectile function and sexual satisfaction (PMID: 42059569).

Studied for: Depression with SSRI-induced sexual dysfunction in men

Adjunctive therapy with SSRI; large sample size; cultural and demographic limitations.

Lactobacillus acidophilus

RCT in premenopausal and menopausal women showed improved FSFI scores and menopause quality of life after 8 weeks (PMID: 41326645).

Studied for: Premenopausal and menopausal women with sexual dysfunction

Single strain supplementation; improvements in sexual function and quality of life.

Bacillus coagulans

RCT in children with hand, foot and mouth disease showed improved immune function and quality of life, indirectly relevant to sexual health (PMID: 41248651).

Studied for: Immune-related conditions

Evidence for sexual function improvement is indirect; primarily immune and quality of life benefits.

Lactobacillus crispatus (intravaginal)

RCT for bacterial vaginosis treatment showed high satisfaction and improved vaginal health (PMID: 17125424).

Studied for: Bacterial vaginosis

Improves vaginal microbiota and health, which may influence sexual satisfaction.

Bifidobacterium longum subsp. infantis (part of multi-strain probiotic)

RCT in male soccer players showed improved anaerobic power and lower-body strength when combined with casein (PMID: 40353739).

Studied for: Athletic performance

Performance-related benefits may indirectly affect sexual health; combined with casein.

View products containing microorganisms linked to this analysis

👥 Who may benefit

Women with depressive disorders undergoing SSRI treatment experiencing sexual dysfunction Men with mild to moderate depression on SSRIs with sexual dysfunction Women with polycystic ovary syndrome Postmenopausal women with sexual dysfunction Patients with progressive multiple sclerosis Women using pessaries for pelvic organ prolapse Athletes seeking improved physical performance that may indirectly influence sexual health

✅ Safety

Probiotic supplementation was generally well tolerated across studies with rare and mild adverse events reported. No serious safety concerns were identified in the reviewed trials involving various strains including Bifidobacterium bifidum, Lactobacillus acidophilus, Bacillus coagulans, and others. However, long-term safety data are limited.

⚠️ Limitations

Most evidence is limited to specific clinical populations (e.g., depression with SSRI treatment, PCOS, postmenopausal women) and may not generalize to healthy individuals seeking sexual function improvement. Intervention durations were typically short (6-8 weeks). Some studies had limited sample sizes or were conducted in culturally homogenous populations. There is a lack of long-term follow-up data. Effects are strain-specific and cannot be generalized across all probiotics. Evidence for direct improvement of sexual function in healthy populations is lacking. More large-scale, diverse, and long-term RCTs are needed.